ONYX TAE for dAVF
Phase 3
Completed
- Conditions
- dural arteriovenous fistula
- Registration Number
- JPRN-jRCT1092220164
- Lead Sponsor
- obuyuki Sakai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
1. modified Rankin Scale 4 or less 2. primary or recurrence of dural arteriovenous fistula
3. difficult to cure by trensvenous embolization
4. exist feeding artery suitable for ONYX embolization
Exclusion Criteria
1. not indicated for intravenous heparin
2. difficult to follow-up for 6 months
3. allergy for iodine contrast
4. allergy for tantalum
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method